KMDA

Kamada Ltd.

Price

$8.04

return (12m)

20.37%

p/e

20.21

p/bv

1.67

DIVIDEND YIELD

3.21%

KMDA price

Kamada

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment KMDA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

6.22%

3 months

9.99%

1 year

20.37%

2 years

59.17%

5 years

62.14%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals KMDA

Valuation

P/E

20.21

Sector -3.53

Industry -3.53

P/BV

1.67

Sector 2.06

Industry 2.06

P/Revenue (PSR)

2.34

Sector 2.02

Industry 2.02

EV/EBITDA

26.27

Sector -222.67

Industry -222.67

EV/EBIT

35.95

Sector -47.57

Industry -47.57

P/EBITDA

10.45

Sector -21.45

Industry -21.45

P/EBIT

16.23

Sector -28.49

Industry -28.49

P/Total Assets

1.17

Sector 1.20

Industry 1.20

P/Net Current Assets

5.23

Sector -10.32

Industry -10.32

P/Working Capital

2.99

Sector -169.93

Industry -169.93

EPS

0.38

Sector -1.79

Industry -1.79

BVPS

4.66

Sector 2.05

Industry 2.05

Efficiency

Gross Margin

40.82%

Sector 41.30%

Industry 41.30%

EBITDA Margin

26.31%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

19.23%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

14.51%

Sector -35.21%

Industry -35.21%

Net Profit Margins

11.60%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.14

Sector 0.02

Industry 0.02

Profitability

ROE

8.25%

Sector -56.67%

Industry -56.67%

ROA

5.81%

Sector -59.91%

Industry -59.91%

ROIC

12.92%

Sector -2,349.21%

Industry -2,349.21%

Dividends

Dividend yield

3.21%

Sector -

Industry -

Payout

64.87%

Sector -

Industry -

Debt

Current Ratio

4.06

Sector 2.88

Industry 2.88

Net Debt / EBITDA

-4.85

Sector -14,043,974.86

Industry -14,043,974.86

Net Debt / EBIT

-6.64

Sector -8.02

Industry -8.02

Net Debt / Equity

-0.26

Sector -32,936.86

Industry -32,936.86

Gross Debt / Equity

0.00

Sector -0.84

Industry -0.84

Equity/Assets

0.70

Sector 0.46

Industry 0.46

Liabilities/Assets

0.30

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

13.11%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals KMDA

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Kamada ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$8.04

Fair Value

$6.31

Upside

-21.49%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
KMDA Kamada Ltd.	$8.04	20.37%	3.21%	20.21	1.67	8.25%	11.60%
JNJ Johnson & Johnson	$264.37	51.83%	1.98%	30.47	7.54	24.76%	21.48%
PFE Pfizer Inc.	$27.50	23.30%	6.24%	35.93	1.84	5.11%	6.86%
ABBV AbbVie Inc.	$263.69	24.63%	2.65%	72.22	-76.87	-106.44%	9.81%
NVO Novo Nordisk A/S	$42.73	-19.34%	4.32%	10.50	5.58	53.11%	35.32%
MRK Merck & Co. Inc.	$143.48	80.02%	2.33%	112.32	8.48	7.55%	4.76%
AZN AstraZeneca PLC	$163.21	6.36%	2.03%	19.00	4.89	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$63.76	44.55%	3.96%	13.95	5.80	41.55%	18.85%
ZTS Zoetis Inc.	$73.56	-49.41%	2.89%	11.41	9.59	84.02%	27.77%
AMGN Amgen Inc.	$378.12	40.58%	2.25%	26.93	20.14	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$779.26	36.63%	0.47%	18.62	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$106.73	38.79%	0.00%	30.46	87.77	288.13%	24.86%
MCK McKesson Corporation	$896.58	26.67%	0.37%	19.68	-26.99	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$514.66	30.45%	0.00%	29.63	6.45	21.76%	35.00%
CAH Cardinal Health Inc.	$232.56	54.70%	0.88%	31.71	-20.07	-63.29%	0.68%
ARGX argenx SE	$994.76	31.52%	0.00%	2.61	3.00	114.60%	44.55%
HRMY Harmony Biosciences Holdings Inc.	$41.09	26.86%	0.00%	13.26	2.41	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

KMDA Historical Dividends

current DY: 3.21%

5-year average DY: 2.96%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	08/26/2026	09/17/2026	0.17000000
Dividends	03/20/2026	04/06/2026	0.24960000
Dividends	03/14/2025	04/07/2025	0.20000000

ABOUT Kamada

Kamada Ltd.

Average Investor10 user rating

4.0 (0 people)

United States

36 years

Founded: 1990

2013

Time since IPO - 13 years

408

Employees

Kamada Ltd. (United States) is listed on the Nasdaq and has a market capitalization of $449.79 million, with shareholders equity totaling $269.56 million.

The company employs approximately 408 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Kamada Ltd. reported $191.85 million in revenue, generating net income of $22.25 million.

Key financial metrics include a P/E ratio of 20.21, a price-to-book (P/B) ratio of 1.67, and a trailing twelve-month dividend yield of 3.21%.

The company trades under the ticker KMDA.

Market cap

$449.79 million

Net worth

$269.56 million

$269,558,000.00

Assets

$383.16 million

$383,162,000.00

Total Shares Outstanding

57.89 million

57,887,000

Average Daily Trading Volume

$108.84 Thousand

$108,844.22

Sector

Health Care

Industry

Biotechnology

KMDA

KMDA revenue and profits

Financial Results KMDA

DRAG THE FRAME TO SEE MORE DATA

KMDA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$896.58 28,21% (12M)

P/E

19.68

0.37%

ROE

-137.16%

P/BV

-26.99

CAH - Cardinal Health

$232.56 56,73% (12M)

P/E

31.71

0.88%

ROE

-63.29%

P/BV

-20.07

JNJ - Johnson & Johnson

$264.37 52,40% (12M)

P/E

30.47

1.98%

ROE

24.76%

P/BV

7.54

ABBV - AbbVie

$263.69 25,04% (12M)

P/E

72.22

2.65%

ROE

-106.44%

P/BV

-76.87

MRK - Merck & Co.

$143.48 83,99% (12M)

P/E

112.32

2.33%

ROE

7.55%

P/BV

8.48

AZN - AstraZeneca

$163.21 7,03% (12M)

P/E

19.00

2.03%

ROE

25.77%

P/BV

4.89

PFE - Pfizer

$27.50 22,78% (12M)

P/E

35.93

6.24%

ROE

5.11%

P/BV

1.84

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$896.58 28,21% (12 M)

P/L

19.68

0.37%

ROE

-137.16%

P/VP

-26.99

CAH - Cardinal Health

$232.56 56,73% (12 M)

P/L

31.71

0.88%

ROE

-63.29%

P/VP

-20.07

JNJ - Johnson & Johnson

$264.37 52,40% (12 M)

P/L

30.47

1.98%

ROE

24.76%

P/VP

7.54

ABBV - AbbVie

$263.69 25,04% (12 M)

P/L

72.22

2.65%

ROE

-106.44%

P/VP

-76.87

MRK - Merck & Co.

$143.48 83,99% (12 M)

P/L

112.32

2.33%

ROE

7.55%

P/VP

8.48

AZN - AstraZeneca

$163.21 7,03% (12 M)

P/L

19.00

2.03%

ROE

25.77%

P/VP

4.89

PFE - Pfizer

$27.50 22,78% (12 M)

P/L

35.93

6.24%

ROE

5.11%

P/VP

1.84

Frequently Asked Questions

What is the price of Kamada (KMDA) today?

A cotação de Kamada (KMDA) hoje está em US$ 8.04, com uma variação de 20.37% em relação ao último ano. A cotação de Kamada (KMDA) iniciou o ano negociando na casa dos US$ 7.06 e hoje está em US$ 8.04. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Kamada (KMDA) e dados de ações do Ibovespa e mercados internacionais.

Quando Kamada (KMDA) paga dividendos?

No último ano, Kamada (KMDA) distribuiu dividendos no mês de April, totalizando US$ 0.25. O Dividend Yield referente aos 12 últimos meses é de 3.21%.

Is Kamada (KMDA) a good investment?

Atualmente, Kamada (KMDA) está cotada a US$ 8.04, com um P/L de 20.21, representando um desvio de 640% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 20.37 em sua cotação e distribuiu US$ 0.25 em dividendos, resultando em um Dividend Yield de 3.21%. O retorno total do acionista foi de 20.37%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Kamada (KMDA) stock?

Investir em ações de Kamada (KMDA) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Kamada (KMDA) yield today?

A rentabilidade de Kamada (KMDA) foi de 6.22% no último mês, 20.37% no último ano e 62.14% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.25 em dividendos, um Dividend Yield de 3.21%.

Se você quisesse comprar 100 ações de Kamada (KMDA) hoje, o investimento total seria de US$ 804.00, com base na cotação atual de US$ 8.04.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 967.77
Em 5 anos: US$ 1,303.61
Em 10 anos: US$ 804.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

KMDA

Kamada Ltd.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment KMDA

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

COMPARING KMDA WITH OTHER STOCK

current DY: 3.21%

5-year average DY: 2.96%

type

Ex - Dividend Date

payment date

value

ABOUT Kamada

Kamada Ltd.

United States

36 years

2013

408

PROFIT X PRICE KMDA

Financial Results KMDA

KMDA cash flow

Asset, Revenue and Profit Growth - KMDA

KMDA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions